{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T12:08:10Z","timestamp":1769774890929,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,29]]},"DOI":"10.7759\/cureus.102584","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T20:41:58Z","timestamp":1769719318000},"source":"Crossref","is-referenced-by-count":0,"title":["Withdrawal Syndrome Following Opioid Rotation: Tramadol and Its Unique Pharmacology"],"prefix":"10.7759","author":[{"given":"Matthew A","family":"Murphy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030591","article-title":"Update on prevalence of pain in patients with cancer 2022: a systematic literature review and meta-analysis","volume":"15","author":"Snijders RA","year":"2023","unstructured":"Snijders RA, Brom L, Theunissen M, van den Beuken-van Everdingen MH. Update on prevalence of pain in patients with cancer 2022: a systematic literature review and meta-analysis. Cancers (Basel). 2023, 15:591. 10.3390\/cancers15030591","journal-title":"Cancers (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.02198","article-title":"Use of opioids for adults with pain from cancer or cancer treatment: ASCO guideline","volume":"41","author":"Paice JA","year":"2023","unstructured":"Paice JA, Bohlke K, Barton D, et al.. Use of opioids for adults with pain from cancer or cancer treatment: ASCO guideline. J Clin Oncol. 2023, 41:914-930. 10.1200\/JCO.22.02198","journal-title":"J Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s44158-024-00201-2","article-title":"Opioid system and related ligands: from the past to future perspectives","volume":"4","author":"Rullo L","year":"2024","unstructured":"Rullo L, Morosini C, Lacorte A, Cristani M, Coluzzi F, Candeletti S, Romualdi P. Opioid system and related ligands: from the past to future perspectives. J Anesth Analg Crit Care. 2024, 4:70. 10.1186\/s44158-024-00201-2","journal-title":"J Anesth Analg Crit Care"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2147\/PGPM.S23422","article-title":"Pharmacogenomic considerations in opioid analgesia","volume":"5","author":"Vuilleumier PH","year":"2012","unstructured":"Vuilleumier PH, Stamer UM, Landau R. Pharmacogenomic considerations in opioid analgesia. Pharmgenomics Pers Med. 2012, 5:73-87. 10.2147\/PGPM.S23422","journal-title":"Pharmgenomics Pers Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S170269","article-title":"Practical management of opioid rotation and equianalgesia","volume":"11","author":"Treillet E","year":"2018","unstructured":"Treillet E, Laurent S, Hadjiat Y. Practical management of opioid rotation and equianalgesia. J Pain Res. 2018, 11:2587-2601. 10.2147\/JPR.S170269","journal-title":"J Pain Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-021-01515-z","article-title":"Tapentadol versus tramadol: a narrative and comparative review of their pharmacological, efficacy and safety profiles in adult patients","volume":"81","author":"Roulet L","year":"2021","unstructured":"Roulet L, Rollason V, Desmeules J, Piguet V. Tapentadol versus tramadol: a narrative and comparative review of their pharmacological, efficacy and safety profiles in adult patients. Drugs. 2021, 81:1257-1272. 10.1007\/s40265-021-01515-z","journal-title":"Drugs"},{"key":"ref7","unstructured":"Food and Drug Administration. Duragesic\u00ae (fentanyl transdermal system) [package insert]. (2023). Accessed. January 12, 2026: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/019813s079lbl.pdf."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13114","article-title":"Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: current understanding and approaches to management","volume":"45","author":"Pergolizzi JV Jr","year":"2020","unstructured":"Pergolizzi JV Jr, Raffa RB, Rosenblatt MH. Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: current understanding and approaches to management. J Clin Pharm Ther. 2020, 45:892-903. 10.1111\/jcpt.13114","journal-title":"J Clin Pharm Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.37573\/9781585284306","article-title":"Demystifying Opioid Conversion Calculations: A Guide for Effective Dosing","author":"McPherson ML","year":"2018","unstructured":"McPherson ML. Demystifying Opioid Conversion Calculations: A Guide for Effective Dosing. American Society of Health\u2011System Pharmacists, Bethesda, MD; 2018. 10.37573\/9781585284306"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2009.06.002","article-title":"Establishing \"best practices\" for opioid rotation: conclusions of an expert panel","volume":"38","author":"Fine PG","year":"2009","unstructured":"Fine PG, Portenoy RK. Establishing \"best practices\" for opioid rotation: conclusions of an expert panel. J Pain Symptom Manage. 2009, 38:418-425. 10.1016\/j.jpainsymman.2009.06.002","journal-title":"J Pain Symptom Manage"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2008.0027","article-title":"Opioid rotation in patients with cancer: a review of the current literature","volume":"4","author":"Vadalouca A","year":"2008","unstructured":"Vadalouca A, Moka E, Argyra E, Sikioti P, Siafaka I. Opioid rotation in patients with cancer: a review of the current literature. J Opioid Manag. 2008, 4:213-250. 10.5055\/jom.2008.0027","journal-title":"J Opioid Manag"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2018.0135","article-title":"Opioid rotation in cancer pain treatment","volume":"115","author":"Schuster M","year":"2018","unstructured":"Schuster M, Bayer O, Heid F, Laufenberg-Feldmann R. Opioid rotation in cancer pain treatment. Dtsch Arztebl Int. 2018, 115:135-142. 10.3238\/arztebl.2018.0135","journal-title":"Dtsch Arztebl Int"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-025-09286-z","article-title":"Opioid conversion in adults with cancer: MASCC-ASCO-AAHPM-HPNA-NICSO guideline","volume":"33","author":"Davis MP","year":"2025","unstructured":"Davis MP, Davies A, McPherson ML, et al.. Opioid conversion in adults with cancer: MASCC-ASCO-AAHPM-HPNA-NICSO guideline. Support Care Cancer. 2025, 33:243. 10.1007\/s00520-025-09286-z","journal-title":"Support Care Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200443130-00004","article-title":"Clinical pharmacology of tramadol","volume":"43","author":"Grond S","year":"2004","unstructured":"Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet. 2004, 43:879-923. 10.2165\/00003088-200443130-00004","journal-title":"Clin Pharmacokinet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(99)00060-3","article-title":"High-dose tramadol in comparison to low-dose morphine for cancer pain relief","volume":"18","author":"Grond S","year":"1999","unstructured":"Grond S, Radbruch L, Meuser T, Loick G, Sabatowski R, Lehmann KA. High-dose tramadol in comparison to low-dose morphine for cancer pain relief. J Pain Symptom Manage. 1999, 18:174-179. 10.1016\/S0885-3924(99)00060-3","journal-title":"J Pain Symptom Manage"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0000000000000057","article-title":"PharmGKB summary: tramadol pathway","volume":"24","author":"Gong L","year":"2014","unstructured":"Gong L, Stamer UM, Tzvetkov MV, Altman RB, Klein TE. PharmGKB summary: tramadol pathway. Pharmacogenet Genomics. 2014, 24:374-380. 10.1097\/FPC.0000000000000057","journal-title":"Pharmacogenet Genomics"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00540-014-1946-z","article-title":"\u00b5-Opioid receptor activation by tramadol and O-desmethyltramadol (M1)","volume":"29","author":"Minami K","year":"2015","unstructured":"Minami K, Sudo Y, Miyano K, Murphy RS, Uezono Y. \u00b5-Opioid receptor activation by tramadol and O-desmethyltramadol (M1). J Anesth. 2015, 29:475-479. 10.1007\/s00540-014-1946-z","journal-title":"J Anesth"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-9338(15)30863-4","article-title":"Psychosis following tramadol withdrawal: a case report","volume":"30","author":"Lakhal MH","year":"2015","unstructured":"Lakhal MH, Moula O, Bahrini L, Maamri A, Zalila H. Psychosis following tramadol withdrawal: a case report. European Psychiatry. 2015, 30:1095. 10.1016\/S0924-9338(15)30863-4","journal-title":"European Psychiatry"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000487","article-title":"A comparative study of the efficacy of venlafaxine and naltrexone for relapse prevention in patients with opioid use disorder attributed to tramadol","volume":"39","author":"Bassiony MM","year":"2024","unstructured":"Bassiony MM, Abdelfattah NR, Elshabrawy A, Adly MM. A comparative study of the efficacy of venlafaxine and naltrexone for relapse prevention in patients with opioid use disorder attributed to tramadol. Int Clin Psychopharmacol. 2024, 39:341-349. 10.1097\/YIC.0000000000000487","journal-title":"Int Clin Psychopharmacol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002024.pub5","article-title":"Alpha\u2082-adrenergic agonists for the management of opioid withdrawal","volume":"2016","author":"Gowing L","year":"2016","unstructured":"Gowing L, Farrell M, Ali R, White JM. Alpha\u2082-adrenergic agonists for the management of opioid withdrawal. Cochrane Database Syst Rev. 2016, 2016:CD002024. 10.1002\/14651858.CD002024.pub5","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/454936-withdrawal-syndrome-following-opioid-rotation-tramadol-and-its-unique-pharmacology","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T20:41:59Z","timestamp":1769719319000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/454936-withdrawal-syndrome-following-opioid-rotation-tramadol-and-its-unique-pharmacology"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.102584","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,29]]}}}